Clinical trials recruiting for Refractory Malignant Solid Neoplasm
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Massachusetts | 2 |
| Texas | 2 |
| Alabama | 1 |
| Arizona | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Indiana | 1 |
Top cities
Self-screener
Recruiting trials
- AOH1996 for the Treatment of Refractory Solid Tumors
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
- Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
Related conditions
Trials recruiting for Refractory Malignant Solid Neoplasm often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Refractory Malignant Solid Neoplasm trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.